Shortcut Navigation:

Breast Cancer News

In this section, access cutting-edge triple-negative breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.

After Some Breast Cancer Treatments, Risk for Other Health Conditions May Rise

A recent study suggests that while women are living longer after treatment for breast cancer, they may be at greater risk of developing certain health conditions as they age.

Yoga May Lower Fatigue, Inflammation After Breast Cancer Treatment

According to a study recently published in the Journal of Clinical Oncology, practicing Hatha yoga for as few as 3 months may lessen fatigue and inflammation in people treated for breast cancer.

News From the San Antonio Breast Cancer Symposium

Each December, medical experts and researchers from around the world meet at the 5-day San Antonio Breast Cancer Symposium to share the latest findings from breast cancer clinical trials. Read on for updates from the 2013 symposium, held December 10–14.

AbbVie Drug Shows Promise Against Difficult Type of Breast Cancer

(Reuters) - Women with an especially deadly type of breast cancer who received a treatment regimen containing an experimental AbbVie Inc drug prior to surgery are likely to have a significantly better response than those who get a standard chemotherapy regimen, according to data from a clinical trial.

Researchers Find Age-specific Breast Cancer Incidences Vary by Race

A study suggests age-specific incidences of breast cancer subtypes vary by race, showing that the differences by race occur only when tumor subtypes are grouped together. 

Chemotherapy Before Surgery May Be Most Beneficial in Very Young Women

Research shows younger women given pre-surgical, or neoadjuvant, chemotherapy are more likely to have a complete response to that treatment than older women. 

Bevacizumab Studies Show Benefit in Early Breast Cancer

Learn about results from two studies that show adding bevacizumab (Avastin) to chemotherapy before surgery improves the rate of pathologic complete response in HER2 negative breast cancer that has not traveled to other parts of the body.

Beta-blockers tied to breast cancer survival

NEW YORK (Reuters Health) - Women with breast cancer who take common blood pressure drugs may have better odds of surviving the disease, according to two preliminary studies.

Being too fat raises risk of deadly breast cancer

CHICAGO (Reuters) - Scientists know that being overweight increases the risk of breast cancers fed by estrogen, but being too fat may also increase the risk of triple-negative breast cancers, a less common and far more deadly type, U.S. researchers said on Tuesday.

Erbitux may help fight breast cancer, claims study

MILAN (Reuters) - An established targeted therapy for bowel cancer may also help women with an aggressive form of breast cancer, a mid-stage clinical study revealed on Monday, opening up a potential new market for the medicine.

close